MOTS-C 10mg

Description

Australian Peptides supplies MOTS-C 10mg as a reference material for laboratory research. Each vial holds 10mg of lyophilised peptide. We seal every vial under vacuum and ship from Australian stock. This product is strictly for laboratory use only, and not for human or animal use, consumption, or therapeutic use.

MOTS-C 10mg specifications

MOTS-c is a mitochondrial-derived peptide of 16 amino acids. Unlike most peptides in this catalogue, the mitochondrial genome encodes it directly, within the 12S ribosomal RNA gene. Researchers therefore group it with the mitochondrial-derived peptides rather than with the synthetic analogues of nuclear-encoded proteins. We state the exact sequence and the measured mass for your lot on the certificate of analysis.

An independent laboratory assays every batch of MOTS-C 10mg at 99% or greater purity by HPLC. In addition, we provide the mass spectrometry report for the current lot on request. Batch numbers appear on the vial label, so you can trace any result back to the matching analysis.

The powder arrives white to off-white in a sealed glass vial. The vial carries a rubber stopper and an aluminium crimp seal. We add no excipients, carriers or preservatives.

Storage, reconstitution and handling

Lyophilised peptide stays stable at ambient temperature in transit. However, move it to -20°C on arrival and keep it away from direct light. To reconstitute, add bacteriostatic water. For example, 2mL yields a working concentration of 5mg/mL.

Direct the diluent slowly down the inside wall of the vial rather than onto the powder. Then swirl gently. Never shake the vial, because agitation can shear the peptide chain. Afterwards, hold the vial at 2–8°C, use it within four weeks, and never refreeze it. We stock Bacteriostatic Water 3mL separately.

Research context

MOTS-c appears in the published literature mainly in metabolic and exercise-physiology models. PubMed indexes the 2015 paper that first characterised it for researchers who want the primary sources. However, researchers have not established efficacy in humans, and we make no therapeutic claims of any kind. Finally, teams studying comparable pathways often also stock GHK-Cu 50mg.

MOTS-c research centres on mitochondrial function and metabolic regulation, which overlaps directly with triple receptor agonist work. Researchers comparing metabolic compounds therefore also review our retatrutide range, R3TA 10mg (retatrutide) and R3TA 20mg (retatrutide), alongside our guide to buying retatrutide in Australia.